r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

VL

Vivo Opportunity, LLC

Insider · 10% owner · INM

Vivo Opportunity, LLC files insider transactions with the SEC as a 10% owner of InMed Pharmaceuticals (INM). We hold 15 disclosed purchases and sales filed since 31 January 2020, 6 of them in the last 90 days.

  • Files forINM
  • Disclosed buys and sells15 in all, 6 in the last 90 days
  • Last disclosure16 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 May 2026 — 16 July 202610% owner · InMed Pharmaceuticals (INM)30 Form 4 lines · source: SEC Form 4
  • Filed 27 August 2024 — 29 August 202410% owner · Soleno Therapeutics (SLNO)3 Form 4 lines · source: SEC Form 4
  • Filed 7 September 2022 — 3 April 202410% owner · Terns Pharmaceuticals (TERN)10 Form 4 lines · source: SEC Form 4
  • Filed 29 January 2020 — 1 July 2022Director and 10% owner · Sierra Oncology (SRRA)18 Form 4 lines · source: SEC Form 4

Everything they disclosed

61 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.